Balyasny Asset Management LLC Novo Cure LTD Call Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$16.15 - $42.35 $5.25 Million - $13.8 Million
-325,000 Reduced 83.33%
65,000 $1.05 Million
Q2 2023

Aug 14, 2023
BUY
$40.29 - $82.51 $13.1 Million - $26.8 Million
325,000 Added 500.0%
390,000 $16.2 Million
Q1 2023

May 15, 2023
BUY
$56.44 - $118.81 $3.67 Million - $7.72 Million
65,000 New
65,000 $3.91 Million
Q1 2022

May 16, 2022
BUY
$60.15 - $84.52 $1.43 Million - $2.01 Million
23,800 New
23,800 $1.97 Million

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email